Manulife (Manufacturers Life Insurance)
ENZ

Manulife (Manufacturers Life Insurance)’s Enzo Biochem, Inc. ENZ Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,955
Closed -$10.7K – 3002
2024
Q4 		$10.7K Hold
14,955
– – ﹤0.01% 2966
2024
Q3 		$16.8K Hold
14,955
– – ﹤0.01% 2993
2024
Q2 		$16.3K Buy
+14,955
New +$16.8K ﹤0.01% 2954
2021
Q2 		– Sell
-22,942
Closed -$79K – 3307
2021
Q1 		$79K Buy
+22,942
New +$71.4K ﹤0.01% 3057
2020
Q4 		– Sell
-10,084
Closed -$21K – 3033
2020
Q3 		$21K Hold
10,084
– – ﹤0.01% 2900
2020
Q2 		$23K Sell
10,084
-21,080
-68% -$54.2K ﹤0.01% 2834
2020
Q1 		$79K Buy
31,164
+1,418
+5% +$3.48K ﹤0.01% 2645
2019
Q4 		$78K Sell
29,746
-2,606
-8% -$7.78K ﹤0.01% 2832
2019
Q3 		$119K Sell
32,352
-300
-0.9% -$1.06K ﹤0.01% 2789
2019
Q2 		$110K Sell
32,652
-2,392
-7% -$8.43K ﹤0.01% 2872
2019
Q1 		$96K Sell
35,044
-2,904,182
-99% -$9.51M ﹤0.01% 2579
2018
Q4 		$8.17M Buy
2,939,226
+963,308
+49% +$3.16M 0.01% 900
2018
Q3 		$8.14M Buy
1,975,918
+249,896
+14% +$1.14M 0.01% 993
2018
Q2 		$8.96M Buy
1,726,022
+1,691,152
+4,850% +$10.3M 0.01% 948
2018
Q1 		$191K Buy
34,870
+2,141
+7% +$15.1K ﹤0.01% 3053
2017
Q4 		$267K Sell
32,729
-151
-0.5% -$1.44K ﹤0.01% 2799
2017
Q3 		$345K Sell
32,880
-1,524
-4% -$16.9K ﹤0.01% 2541
2017
Q2 		$380K Buy
34,404
+2,074
+6% +$19.3K ﹤0.01% 2496
2017
Q1 		$271K Buy
32,330
+3,988
+14% +$28.1K ﹤0.01% 2624
2016
Q4 		$196K Sell
28,342
-1,364
-5% -$8.71K ﹤0.01% 2803
2016
Q3 		$151K Sell
29,706
-124,245
-81% -$742K ﹤0.01% 2985
2016
Q2 		$919K Sell
153,951
-756,068
-83% -$4.2M ﹤0.01% 1674
2016
Q1 		$4.03M Sell
910,019
-216,755
-19% -$965K ﹤0.01% 1144
2015
Q4 		$5.07K Sell
1,126,774
-180,744
-14% -$763K ﹤0.01% 1028
2015
Q3 		$4.14K Buy
1,307,518
+11,540
+0.9% +$35K ﹤0.01% 1109
2015
Q2 		$3.93K Buy
1,295,978
+460,526
+55% +$1.29M ﹤0.01% 1170
2015
Q1 		$2.46K Buy
835,452
+811,094
+3,330% +$2.66M ﹤0.01% 1340
2014
Q4 		$108 Buy
24,358
+400
+2% +$1.91K ﹤0.01% 3049
2014
Q3 		$123 Sell
23,958
-939
-4% -$5.01K ﹤0.01% 2980
2014
Q2 		$130K Buy
24,897
+23,499
+1,681% +$102K ﹤0.01% 3035
2014
Q1 		$6 Hold
1,398
– – ﹤0.01% 3456
2013
Q4 		$4 Hold
1,398
– – ﹤0.01% 3591
2013
Q3 		$4 Hold
1,398
– – ﹤0.01% 3422
2013
Q2 		$3K Buy
+1,398
New +$3.09K ﹤0.01% 3366

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ENZ Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Enzo Biochem, Inc. (ENZ) in Q1 2025, closing a stake of 14,955 shares — an estimated $10.7K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ENZ in Q2 2013 and held it in 34 quarters. The position peaked at $8.96M in Q2 2018. 41 funds tracked by Wall St. Rank hold ENZ as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Enzo Biochem, Inc. position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,955 Enzo Biochem, Inc. shares in Q1 2025, an estimated $10.7K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 34 quarters.
  • Manulife (Manufacturers Life Insurance)'s Enzo Biochem, Inc. position peaked at $8.96M in Q2 2018.
  • 41 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.